Sully Erin K, Malachowa Natalia, Elmore Bradley O, Alexander Susan M, Femling Jon K, Gray Brian M, DeLeo Frank R, Otto Michael, Cheung Ambrose L, Edwards Bruce S, Sklar Larry A, Horswill Alexander R, Hall Pamela R, Gresham Hattie D
Research Service, New Mexico Veterans Affairs Medical Center, Albuquerque, New Mexico, United States of America; Division of Infectious Diseases, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America.
Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
PLoS Pathog. 2014 Jun 12;10(6):e1004174. doi: 10.1371/journal.ppat.1004174. eCollection 2014 Jun.
Bacterial signaling systems are prime drug targets for combating the global health threat of antibiotic resistant bacterial infections including those caused by Staphylococcus aureus. S. aureus is the primary cause of acute bacterial skin and soft tissue infections (SSTIs) and the quorum sensing operon agr is causally associated with these. Whether efficacious chemical inhibitors of agr signaling can be developed that promote host defense against SSTIs while sparing the normal microbiota of the skin is unknown. In a high throughput screen, we identified a small molecule inhibitor (SMI), savirin (S. aureus virulence inhibitor) that disrupted agr-mediated quorum sensing in this pathogen but not in the important skin commensal Staphylococcus epidermidis. Mechanistic studies employing electrophoretic mobility shift assays and a novel AgrA activation reporter strain revealed the transcriptional regulator AgrA as the target of inhibition within the pathogen, preventing virulence gene upregulation. Consistent with its minimal impact on exponential phase growth, including skin microbiota members, savirin did not provoke stress responses or membrane dysfunction induced by conventional antibiotics as determined by transcriptional profiling and membrane potential and integrity studies. Importantly, savirin was efficacious in two murine skin infection models, abating tissue injury and selectively promoting clearance of agr+ but not Δagr bacteria when administered at the time of infection or delayed until maximal abscess development. The mechanism of enhanced host defense involved in part enhanced intracellular killing of agr+ but not Δagr in macrophages and by low pH. Notably, resistance or tolerance to savirin inhibition of agr was not observed after multiple passages either in vivo or in vitro where under the same conditions resistance to growth inhibition was induced after passage with conventional antibiotics. Therefore, chemical inhibitors can selectively target AgrA in S. aureus to promote host defense while sparing agr signaling in S. epidermidis and limiting resistance development.
细菌信号系统是对抗包括金黄色葡萄球菌引起的抗生素耐药性细菌感染这一全球健康威胁的主要药物靶点。金黄色葡萄球菌是急性细菌性皮肤和软组织感染(SSTIs)的主要病因,群体感应操纵子agr与之有因果关系。能否开发出有效的agr信号化学抑制剂,在促进宿主抵御SSTIs的同时,保护皮肤正常微生物群,目前尚不清楚。在一项高通量筛选中,我们鉴定出一种小分子抑制剂(SMI),即savirin(金黄色葡萄球菌毒力抑制剂),它能破坏该病原体中agr介导的群体感应,但对重要的皮肤共生菌表皮葡萄球菌却不起作用。采用电泳迁移率变动分析和一种新型AgrA激活报告菌株进行的机制研究表明,转录调节因子AgrA是病原体中的抑制靶点,可防止毒力基因上调。正如其对包括皮肤微生物群成员在内的指数生长期生长影响极小一样,通过转录谱分析以及膜电位和完整性研究确定,savirin不会引发传统抗生素诱导的应激反应或膜功能障碍。重要的是,savirin在两种小鼠皮肤感染模型中均有效,在感染时给药或延迟至脓肿发展至最大程度时给药,均可减轻组织损伤,并选择性促进agr + 细菌而非Δagr细菌的清除。增强宿主防御的机制部分涉及巨噬细胞中对agr + 而非Δagr的细胞内杀伤增强以及低pH环境。值得注意的是,在体内或体外多次传代后,均未观察到对savirin抑制agr的耐药性或耐受性,而在相同条件下,用传统抗生素传代后会诱导生长抑制耐药性。因此,化学抑制剂可选择性靶向金黄色葡萄球菌中的AgrA,以促进宿主防御,同时保留表皮葡萄球菌中的agr信号并限制耐药性的发展。